UK MPs call for no limit on drug prices for ultra-orphan diseases
LONDON – A majority of members of parliament (MPs) say there should be no limit on the price per patient paid for drugs to treat ultra-orphan diseases, according to a survey commissioned by the UK Bioindustry Association (BIA).
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter